Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Meihao Medical, indicating a decline in stock price and a relatively low PE ratio compared to the industry average [1][2] - As of June 5, Meihao Medical's closing price was 16.78 yuan, down 1.35%, with a rolling PE ratio of 26.69 times and a total market capitalization of 9.546 billion yuan [1] - The average PE ratio for the medical device industry is 50.97 times, with a median of 36.67 times, placing Meihao Medical at the 59th position in the industry ranking [1][2] Group 2 - As of the first quarter of 2025, 30 institutions held shares in Meihao Medical, including 24 funds, 4 other institutions, and 2 insurance companies, with a total holding of 42.1394 million shares valued at 1.23 billion yuan [1] - Meihao Medical specializes in the design, development, manufacturing, and sales of precision components and products for medical devices, including home ventilator components and cochlear implant components [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 296 million yuan, a year-on-year increase of 5.05%, and a net profit of 51.875 million yuan, a year-on-year decrease of 10.62%, with a gross profit margin of 39.28% [1]
美好医疗收盘下跌1.35%，滚动市盈率26.69倍，总市值95.46亿元